These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2760842)

  • 1. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
    Post JM; Smith JM; Jones AW
    J Pharmacol Exp Ther; 1989 Aug; 250(2):591-7. PubMed ID: 2760842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of arterial 42K efflux by ATP depletion and cromakalim is antagonized by glyburide.
    Post JM; Jones AW
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H848-54. PubMed ID: 1900392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle.
    Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
    Eur J Pharmacol; 1988 Oct; 155(3):229-37. PubMed ID: 3234486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the putative potassium channel activator WAY-120,491 on 86Rb efflux from the rabbit aorta.
    Lodge NJ; Cohen RB; Havens CN; Colatsky TJ
    J Pharmacol Exp Ther; 1991 Feb; 256(2):639-44. PubMed ID: 1899702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue.
    Quast U; Baumlin Y
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):319-26. PubMed ID: 3194039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.
    Duty S; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):1198-204. PubMed ID: 1467840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of actions of BRL 34915 in the rat portal vein.
    Shetty SS; Weiss GB
    Eur J Pharmacol; 1987 Sep; 141(3):485-8. PubMed ID: 3666042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery.
    Bray K; Quast U
    Br J Pharmacol; 1991 Mar; 102(3):585-94. PubMed ID: 1285396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil.
    Coldwell MC; Howlett DR
    Biochem Pharmacol; 1987 Nov; 36(21):3663-9. PubMed ID: 2445348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Ca2+ handling along the arterial tree: an update including studies in human mesenteric resistance vessels.
    Cauvin C; Weir SW; Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S10-5. PubMed ID: 2468888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium efflux enhancement by cromakalim (BRL 34915) in rabbit mesenteric artery: an indirect effect independent of calcium?
    Coldwell MC; Howlett DR
    Biochem Pharmacol; 1988 Nov; 37(21):4105-10. PubMed ID: 3190749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.
    Russell SN; Smirnov SV; Aaronson PI
    Br J Pharmacol; 1992 Mar; 105(3):549-56. PubMed ID: 1628142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diverse effects of noradrenaline and other stimulants on 86Rb and 42K efflux in rabbit and guinea-pig arterial muscle.
    Bolton TB; Clapp LH
    J Physiol; 1984 Oct; 355():43-63. PubMed ID: 6092628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
    Abe S; Nishimura J; Nakamura M; Kanaide H
    J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.